FIELD: medicine.
SUBSTANCE: invention relates cosmetology and dermatology and represents application of a photosensitiser chosen from methyl ester of ALA (aminolevulinic acid), benzyl ester of ALA or substituted benzyl ester of ALA, or their pharmaceutically acceptable salt, in preparing a medical product to be applied in prevention or treatment of acne associated with Propionibacterium.
EFFECT: invention provides effective acne treatment in an individual by 5-aminolevulinic acid (5-ALA) derivatives applied to ensure avoiding such adverse effects as discomfort, burning, itching, acute pain throughout irradiation, edematous erythema, prolonged irritation and hypersensitivity.
13 cl, 13 ex, 2 tbl, 11 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| USING 5-AMINOLEVULINIC ACID AND DERIVATIVES THEREOF IN SOLID FORM FOR PHOTODYNAMIC TREATMENT AND DIAGNOSTICS | 2008 |
|
RU2521228C2 |
| 5-AMINOLEVULINIC ACID ESTERS AS PHOTOSENSITIVE AGENTS IN PHOTOCHEMOTHERAPY | 2001 |
|
RU2246483C2 |
| LOW-MOLECULAR DERIVATIVES OF CARBOXAMIDE HALOGENATED PORPHYRINS, SPECIFICALLY CHLORINES AND BACTERIOCHLORINS, AND USE THEREOF | 2016 |
|
RU2718923C2 |
| ACID ADDITION SALTS OF 5-AMINOLEVULINIC ACID AND ITS DERIVATIVES | 2005 |
|
RU2392266C2 |
| COMPOUNDS | 2013 |
|
RU2635563C2 |
| METHOD FOR PRODUCING CHLORINES AND PHARMACEUTICAL APPLICATIONS THEREOF | 2009 |
|
RU2513483C2 |
| EMITTER | 2009 |
|
RU2487740C2 |
| SEMI-SOLID COMPOSITIONS AND PHARMACEUTICAL PRODUCTS | 2010 |
|
RU2526803C2 |
| EMITTER | 2012 |
|
RU2615870C2 |
| EMITTER | 2009 |
|
RU2619790C2 |
